News & Events
BSE Healthcare index touches new 52-weeks high at 9077.73
US keenly watching Indian moves on compulsory licensing in pharma sector
NPPA still looking for partners to roll out SMS helpline for consumers
India-made, low-cost rotavirus vaccine likely by 2014
DoP to finalise DPR by May end to transform India major drug discovery hub
House panel wants Health Ministry to decide banning Analgin in a month
Panel finds wrong information, names of banned drugs in official website of CDSCO
Drug control department intensifies inspection
Over 200 ethics committees got registered with DCGI after making it mandatory
WHO issues supplementary guidelines on GMP on sterile process validation
Gujarat govt adopts performance based appraisal process to rate FDCA employees
PCI to work closely with pharmacy colleges to ensure better understanding of Pharmacy Act
CDSCO to give priority to approval of new drugs having impact on public health
DCGI to issue first WC certificates to API exporters to EU based on accreditations
‘Get tall’ powder TV ad: HC upholds FDA ban
Parliamentary panel raps Health Ministry for delay in finalizing HIV/AIDS Bill
Govt extends 2D bar code adoption for pharma exports to July 2014
Gulf countries eyeing Indian investment in pharma sector: Report
Industry wants Ayush dept to clarify issue of use of aristolochic acids in ayurvedic drugs
Drug trials: Panel to look into practices of CDSCO
Interactive knowledge session at KDPMA office on 6th April 2013
DCGI suggests plan to ensure GMP-compliant drug plant exporters
US FDA approves diagnostic imaging agent \\\'Lymphoseek\\\', Indian cancer experts welcome
Commerce ministry may step up MAI sops to exporters to cope with burden of GDUFA
Centre finds SLAs granted 23 licenses for FDCs without DCGI approval
SC decision on clinical trials responsible for market uncertainty
Planning Commission recommends interlinking of all drug licensing offices, labs
Health ministry issues notification to make registration of Ethics Committees mandatory for clinical trials
Biotech has made India net exporter of cotton, says expert
DCGI granted power to fix compensation in adverse events during trials
MCI\\\'s recent directive to doctors to prescribe generic names part of IMC Regulation 2002: Dr M C Gupta
DCC meet discusses major issues pertaining to implementation of D&C Act
Parliamentary Standing Committee frets over NIPERs delay
USP sets up three new expert committees for its medicines compendium
Maharashtra FDA embarks on surprise inspection of chemist shops to ensure presence of pharmacists
Lab animal clearance demand by Central govt
Delay in studies blocks final approval of NPPA scheme for statistical system
Pharma Gladiator terms issuance of draft guidelines on GDP by DCGI as illegal and non-implementable
Parliamentary panel expresses concern on delay in developing infrastructure for new NIPERs
FDI issue to be taken up for meeting between Parliamentary Committee, pharma players
New FDA norm welcomed by Indian companies
Centre plans mandatory earmarking of funds to backward regions to promote life sciences, biotechnology
Pharmexcil to organise interactive meeting between industry leaders and visiting delegates from Georgia, USA in Hyderabad
FDA assistant commissioner suspended for neglecting duty
Pharma companies takes measures to seek approval from FDA
Karnataka pharma cos upbeat on draft GDP guidelines as it makes distribution system transparent
Haryana DCA starts online issuance of sale licences; manufacturing licences to follow suit